NZ600266A - Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use - Google Patents

Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use

Info

Publication number
NZ600266A
NZ600266A NZ600266A NZ60026610A NZ600266A NZ 600266 A NZ600266 A NZ 600266A NZ 600266 A NZ600266 A NZ 600266A NZ 60026610 A NZ60026610 A NZ 60026610A NZ 600266 A NZ600266 A NZ 600266A
Authority
NZ
New Zealand
Prior art keywords
compound
methods
preparation
pharmaceutical compositions
certain novel
Prior art date
Application number
NZ600266A
Other languages
English (en)
Inventor
Wei-Guo Su
Weihan Zhang
Hong Jia
Yumin Cui
Yongxin Ren
Yang Sai
Zhenping Wu
Wenji Li
Jiangyong Shao
Zhenping Tian
Original Assignee
Hutchison Medipharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44029398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ600266(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hutchison Medipharma Ltd filed Critical Hutchison Medipharma Ltd
Publication of NZ600266A publication Critical patent/NZ600266A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NZ600266A 2009-11-23 2010-11-23 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use NZ600266A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2009101992592A CN102070618B (zh) 2009-11-23 2009-11-23 一种化合物及其晶体
PCT/CN2010/078997 WO2011060746A1 (en) 2009-11-23 2010-11-23 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use

Publications (1)

Publication Number Publication Date
NZ600266A true NZ600266A (en) 2014-06-27

Family

ID=44029398

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ600266A NZ600266A (en) 2009-11-23 2010-11-23 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use

Country Status (19)

Country Link
US (2) US8658658B2 (ref)
EP (1) EP2504331B1 (ref)
JP (1) JP5758399B2 (ref)
KR (1) KR101513784B1 (ref)
CN (2) CN102070618B (ref)
AU (1) AU2010321366B2 (ref)
BR (1) BR112012012138B1 (ref)
CA (1) CA2781066C (ref)
DK (1) DK2504331T3 (ref)
ES (1) ES2529105T3 (ref)
IN (1) IN2012DN04868A (ref)
MX (1) MX2012005926A (ref)
MY (1) MY161749A (ref)
NZ (1) NZ600266A (ref)
PH (1) PH12012500992A1 (ref)
PL (1) PL2504331T3 (ref)
PT (1) PT2504331E (ref)
RU (1) RU2507203C1 (ref)
WO (1) WO2011060746A1 (ref)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102070618B (zh) 2009-11-23 2013-08-21 和记黄埔医药（上海）有限公司 一种化合物及其晶体
EP3157912B1 (en) * 2014-06-19 2019-02-20 Merial, Inc. Parasiticidal compositions comprising indole derivatives, methods and uses thereof
CN105985326B (zh) * 2015-02-16 2020-04-14 上海宣创生物科技有限公司 嘧啶衍生物晶型ⅲ及其制备方法和用途
WO2016187767A1 (en) * 2015-05-25 2016-12-01 Hutchison Medipharma Limited Pharmaceutical compositions and use thereof
US20190276439A1 (en) * 2016-11-18 2019-09-12 Hutchison Medipharma Limited Method of treating solid tumors
JP2020164434A (ja) * 2019-03-28 2020-10-08 上野製薬株式会社 ２，６−ナフタレンビス（２−オキサゾリン）の製造方法
CN118593700A (zh) * 2020-03-09 2024-09-06 和记黄埔医药（上海）有限公司 抗pd-1抗体和多受体酪氨酸激酶抑制剂的药物组合及其使用方法
BR112023021066A2 (pt) * 2021-04-12 2023-12-12 Mitoimmune Therapeutics Inc Forma cristalina a, método para preparar a forma cristalina a, composição farmacêutica, e, composição

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0509299A (pt) * 2004-03-30 2007-09-18 Taisho Pharmaceutical Co Ltd composto ou um sal, hidrato, ou solvato farmaceuticamente aceitável do mesmo, composição farmacêutica, e, métodos para a profilaxia ou o tratamento de doença, para reduzir ingestão de alimento de um indivìduo, para induzir saciedade em um indivìduo, para controlar ou reduzir ganho de peso em um indivìduo, para modular um receptor de mch em um indivìduo e para produzir uma composição farmacêutica
WO2007035309A1 (en) 2005-09-15 2007-03-29 Merck & Co., Inc. Tyrosine kinase inhibitors
SI2154967T1 (sl) * 2007-04-16 2014-06-30 Hutchison Medipharma Enterprises Limited Offshore Group Chambers Derivati pirimidina
CN101289444B (zh) * 2007-04-16 2012-01-04 和记黄埔医药（上海）有限公司 一种嘧啶衍生物及其医药用途
TW201008933A (en) * 2008-08-29 2010-03-01 Hutchison Medipharma Entpr Ltd Pyrimidine compounds
CN102070618B (zh) * 2009-11-23 2013-08-21 和记黄埔医药（上海）有限公司 一种化合物及其晶体

Also Published As

Publication number Publication date
BR112012012138B1 (pt) 2023-02-07
MX2012005926A (es) 2012-11-23
EP2504331B1 (en) 2014-11-12
CA2781066C (en) 2014-09-16
CN102648194A (zh) 2012-08-22
US20140200232A1 (en) 2014-07-17
JP2013511475A (ja) 2013-04-04
MY161749A (en) 2017-05-15
CN102648194B (zh) 2014-10-29
KR20120097526A (ko) 2012-09-04
CA2781066A1 (en) 2011-05-26
PH12012500992A1 (en) 2016-09-09
CN102070618B (zh) 2013-08-21
JP5758399B2 (ja) 2015-08-05
US8658658B2 (en) 2014-02-25
AU2010321366A1 (en) 2012-06-14
RU2507203C1 (ru) 2014-02-20
CN102070618A (zh) 2011-05-25
BR112012012138A2 (pt) 2017-03-07
US20120270889A1 (en) 2012-10-25
WO2011060746A1 (en) 2011-05-26
RU2012126112A (ru) 2013-12-27
US8946249B2 (en) 2015-02-03
PT2504331E (pt) 2015-02-20
DK2504331T3 (en) 2014-12-08
PL2504331T3 (pl) 2015-04-30
ES2529105T3 (es) 2015-02-16
EP2504331A1 (en) 2012-10-03
AU2010321366B2 (en) 2014-07-24
KR101513784B1 (ko) 2015-04-20
AU2010321366A8 (en) 2012-07-05
IN2012DN04868A (ref) 2015-09-25
EP2504331A4 (en) 2013-04-17

Similar Documents

Publication Publication Date Title
NZ600266A (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
EA201201378A1 (ru) Определенные аминопиримидины, композиции на их основе и способы их использования
NZ600207A (en) Substituted 4-aminocyclohexane derivatives
EA201100503A1 (ru) Глюкозидные производные и их применения
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
EA201000050A1 (ru) Замещенные бициклолактамные соединения
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
EA201170922A1 (ru) Производные сульфонамида
NZ590334A (en) ICOTINIB HYDROCHLORIDE (4-[(3-ethynylphenyl)amino]-6,7-benzo-12-crownquinazoline hydrochloride), SYNTHESIS, CRYSTALLOGRAPHIC FORM, MEDICAL COMBINATION, AND USES THEREOF
NZ603525A (en) Pyrimidine based compound and uses thereof
EA201300250A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
NO20090755L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
MY151295A (en) Pyrimidyl indoline compound
MX353209B (es) Antagonistas d2, metodos de sintesis y metodos de uso.
EA201170722A1 (ru) Лактамы в качестве ингибиторов бета-секретазы
WO2010144499A3 (en) Urea derivatives as kinase inhibitors
EA201101621A1 (ru) Производные бензоксазолона в качестве ингибиторов альдостеронсинтазы
MX2009012125A (es) Compuestos terapeuticos.
EA201001566A1 (ru) Новый класс спиропиперидинов для лечения нейродегенеративных заболеваний
WO2009145591A3 (en) Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof
EA201300389A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
NO20074622L (no) Metabolitter for NK-1 antagonister for brekninger
EA201100502A1 (ru) Гликозидные производные и их применения
ATE546448T1 (de) Urotensin-ii-rezeptorantagonisten
MX2010001512A (es) Nuevo procedimiento de preparacion.

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 NOV 2015 BY COMPUTER PACKAGES INC

Effective date: 20141202

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 NOV 2016 BY COMPUTER PACKAGES INC

Effective date: 20151031

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 NOV 2017 BY COMPUTER PACKAGES INC

Effective date: 20161101

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 NOV 2018 BY COMPUTER PACKAGES INC

Effective date: 20171031

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 NOV 2019 BY COMPUTER PACKAGES INC

Effective date: 20181031

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 NOV 2020 BY COMPUTER PACKAGES INC

Effective date: 20191031

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 NOV 2021 BY COMPUTER PACKAGES INC

Effective date: 20201031

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 NOV 2022 BY COMPUTER PACKAGES INC

Effective date: 20211030

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 NOV 2023 BY COMPUTER PACKAGES INC

Effective date: 20221030

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 NOV 2024 BY COMPUTER PACKAGES INC

Effective date: 20231030

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 NOV 2025 BY COMPUTER PACKAGES INC

Effective date: 20241030

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 NOV 2026 BY COMPUTER PACKAGES INC

Effective date: 20251030